Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma

Min Yu(University of Maryland, Baltimore), Zonghai Li(Guizhou Normal University), Hong Luo(Anshan Hospital), Zeyan Pan(Second Military Medical University), Ying Liu(Dalian Medical University), Hua Jiang(State Key Laboratory of Oncogene and Related Genes), Mingliang Fan(Shanghai Jiao Tong University), Xiuqi Wu(Shanghai Jiao Tong University), Bizhi Shi(Shanghai Jiao Tong University), Shengmeng Di(Shanghai Jiao Tong University)
Molecular Therapy
December 19, 2017
Cited by 184


Related Papers